Hyosung Chemical Corp
Hyosung Chemical Corp is a South Korean chemical manufacturer specializing in commodity chemicals, primarily generating revenue through the production and sale of chemical products.
Business. Hyosung Chemical Corp (298000.KS) is a South Korean company operating in the commodity chemicals industry within the basic materials sector. The firm is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Hyosung Chemical Corp (298000.KS) is a South Korean company operating in the commodity chemicals industry within the basic materials sector. The firm is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not available.
Hyosung Chemical Corp exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 28.67, indicating significant reliance on debt financing. The company's liquidity position is constrained, as evidenced by a current ratio of 0.33, suggesting limited short-term liquidity to cover immediate obligations. Despite a market price of 38,900 KRW and a market cap of 146.57 billion KRW, the company's price-to-book ratio of 1.59 and negative net income of 73.9 billion KRW highlight valuation and earnings challenges.
Profitability metrics are severely underperforming relative to industry norms. The company reported a net loss of 73.9 billion KRW, with a return on equity of -0.7997 and a return on assets of -0.0223, both of which are negative and far below the typical performance of firms in the Commodity Chemicals industry. Gross profit and operating income were also negative, at -14.87 billion KRW and -41.3 billion KRW, respectively, indicating operational inefficiencies and cost overruns.
Geographically and segment-wise, the company's revenue is concentrated in a single business segment, as disclosed in its financials, with no material diversification across regions or product lines. This lack of diversification increases exposure to regional economic shifts and sector-specific volatility.
The company's growth trajectory is currently negative, with a free cash flow of -93.92 billion KRW and capital expenditures of -70.69 billion KRW, indicating a cash outflow from operations and investment activities. The outlook for the current fiscal year is not explicitly provided, but the negative operating cash flow of 5.92 billion KRW and the absence of positive revenue growth signals suggest a challenging near-term environment.
Risk factors include a high debt load and negative net cash position, which could limit the company's ability to respond to market pressures or fund operations without external financing. The risk assessment indicates a medium liquidity risk and a low dilution risk, though the company's negative net income and high leverage could necessitate future capital raising, potentially leading to equity dilution.
Recent events, including the latest financial filing, reveal a deteriorating financial position with a net loss and negative operating income. No recent transcripts or filings beyond the financial snapshot are available to provide additional context on management's strategy or operational changes.
- Hyosung Chemical Corp is highly leveraged, with a debt-to-equity ratio of 28.67, indicating significant financial risk.
- The company is currently unprofitable, with a net loss of 73.9 billion KRW and negative returns on equity and assets.
- Revenue and segment diversification are limited, increasing exposure to regional and sector-specific risks.
- Free cash flow is negative, and capital expenditures are outpacing operating cash flow, signaling financial strain.
- Liquidity is constrained, with a current ratio of 0.33 and negative net cash after debt.
Bull / Bear case
Generated · model-assistedNet income surged 220.7% year-over-year to 393 billion KRW, marking a significant turnaround from prior losses.
Free cash flow improved by 64.6% year-over-year, reducing the cash burn rate to 90.3 billion KRW.
Long-term debt decreased significantly to 1.6 trillion KRW, down from 2.7 trillion KRW in the prior fiscal year.
Gross profit narrowed its deficit to 70.5 billion KRW, indicating improving cost management relative to revenue.
The company achieved a positive net income CAGR of 61.1% over the last four years.
The debt-to-equity ratio stands at 28.67, placing it in the bottom quartile compared to 612 peers.
The company faces high credit risk and medium liquidity risk according to internal risk flag assessments.
Revenue declined 4.5% year-over-year to 2.34 trillion KRW, continuing a negative four-year CAGR trend.
In focus — financials by report
Revenue KRW 647.58B; Operating income -KRW 44.39B.
- ▍Revenue KRW 647.58B
- ▍Operating income -KRW 44.39B
- ▍Net margin -15.5%
Revenue KRW 628.86B; Operating income -KRW 30.40B.
- ▍Revenue KRW 628.86B
- ▍Operating income -KRW 30.40B
- ▍Net margin -9.7%
Revenue KRW 597.54B; Operating income -KRW 60.67B.
- ▍Revenue KRW 597.54B
- ▍Operating income -KRW 60.67B
- ▍Net margin -15.1%
Revenue KRW 663.88B; Operating income -KRW 41.30B.
- ▍Revenue KRW 663.88B
- ▍Operating income -KRW 41.30B
- ▍Net margin -11.1%
Revenue KRW 2.45T, −6,5% YoY; Operating income +18,2% YoY.
- ▍Revenue KRW 2.45T, −6,5% YoY
- ▍Operating income +18,2% YoY
- ▍Net income +6,1% YoY
- ▍Free cash flow +3,2% YoY
- ▍Net margin -13.3%
Revenue KRW 2.62T, −8,9% YoY; Operating income +36,5% YoY.
- ▍Revenue KRW 2.62T, −8,9% YoY
- ▍Operating income +36,5% YoY
- ▍Net income +15,2% YoY
- ▍Free cash flow +27,1% YoY
- ▍Net margin -13.2%
Revenue KRW 2.88T, +14,2% YoY; Operating income −346,6% YoY.
- ▍Revenue KRW 2.88T, +14,2% YoY
- ▍Operating income −346,6% YoY
- ▍Net income −799,9% YoY
- ▍Free cash flow −315,4% YoY
- ▍Net margin -14.2%
Revenue KRW 2.52T; Operating income KRW 136.57B.
- ▍Revenue KRW 2.52T
- ▍Operating income KRW 136.57B
- ▍Net margin 2.3%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Hyosung Chemical Corp Market data — financials · 2026-05-26